海普瑞(002399)

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
深圳市海普瑞药业集团股份有限公司
所属行业
医药制造业
上市日期
2010-05-06
注册资本
146729万元
公司概况
深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。
暂无公告

暂不提供行情数据

热议股票

{"pagemeta":{"title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,002399,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"002399","data":{"stockData":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":12.05,"timestamp":1770966192000,"preClose":12.27,"halted":0,"volume":2880116,"delay":0,"changeRate":-0.0179,"floatShares":1247000000,"shares":1467000000,"eps":0.2864,"marketStatus":"已收盘","change":-0.22,"latestTime":"02-13 15:00:00","open":12.33,"high":12.33,"low":12.05,"amount":35076600,"amplitude":0.0228,"askPrice":12.05,"askSize":800,"bidPrice":12.04,"bidSize":11,"shortable":0,"etf":0,"ttmEps":0.2864,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":12.27,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":13.5,"lowLimit":11.04,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1467296204,"isCdr":false,"pbRate":1.46,"roa":"--","peRate":42.074022,"roe":"4.51%","epsLYR":0.4408,"committee":0.15843,"marketValue":17681000000,"turnoverRate":0.0023,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-02-24。","hkstockBrief":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":5.28,"timestamp":1771574916632,"preClose":5.31,"halted":0,"volume":203000,"delay":0,"premium":"-61.30"},"floatMarketCap":15029000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"serverTime":1771762071539,"stockEarnings":[{"period":"1week","weight":-0.0131},{"period":"1month","weight":-0.0203},{"period":"3month","weight":-0.0406},{"period":"6month","weight":-0.0899},{"period":"1year","weight":0.1901},{"period":"ytd","weight":0.0221}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市海普瑞药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2010-05-06","address":"广东省深圳市南山区松坪山郎山路21号","registeredCapital":"146729万元","survey":"　　深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。","listedPrice":148}}}}

海普瑞(002399)

公司概况

热议股票